Search for: "Doe Pharmaceutical" Results 1 - 20 of 7,514
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Nov 2017, 7:26 am by CJ Haddick
Paul Insurance companies owe no duty to defend or indemnify Watson Pharmaceutical in governmental suits against the pharmaceutical company over the deceptive marketing of opioids. [read post]
26 Jan 2023, 1:06 pm by Thorsten Bausch (Hoffmann Eitle)
The proprietors of pharmaceutical formulation and pharmaceutical use patents do often not have it easy, if and when – as is often the case – they have conducted clinical trials before the priority date of their patent. [read post]
25 Jan 2016, 12:00 am by D Daniel Sokol
Brekke (Department of Economics, Norwegian School of Economics); Chiara Canta (Department of Economics, Norwegian School of Economics) and Odd Rune Straume (Universidade do Minho - NIPE) ask Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? [read post]
8 Sep 2015, 12:00 am by D Daniel Sokol
Brekke (Department of Economics, Norwegian School of Economics) ; Chiara Canta (Department of Economics, Norwegian School of Economics) ; and Odd Rune Straume (Universidade do Minho - NIPE) ask Does Reference Pricing Drive Out Generic Competition in Pharmaceutical... [read post]
18 Feb 2010, 3:18 pm by Salcido
  Although the FDA holds pharmaceutical companies to meet certain criteria before a new drug can go on the market, this does not mean that the drugs are defect free. [read post]
12 Feb 2018, 3:02 am by Walter Olson
That’s a Terrible Reason for the FDA to Make It Harder to Get” [Mike Riggs, Reason] Expect runs: “Does anyone see the humor/irony here? [read post]
1 Jul 2011, 12:28 pm by Andrew Dorn
The rule includes other items that are used to delivers pharmaceutical products, such as bottles and IV bags, but does not include sharps or other potentially infectious wastes. [read post]
22 Apr 2017, 6:56 am by Walter Olson
” Tags: pharmaceuticals, Steve Berman Steve Berman takes on pharmaceutical pricing is a post from Overlawyered - Chronicling the high cost of our legal system [read post]
10 Mar 2021, 8:38 pm by Patent Docs
The Register does not implement a patent linkage system that would prevent a generic drug from getting Marketing Authorization before expiry of the originator's patents. [read post]
19 Apr 2017, 9:23 pm by Patent Docs
Such a situation occurred in IPR2014-00784 (Torrent Pharmaceuticals Ltd. v. [read post]
14 Mar 2009, 6:57 am
Levine and other health-related news, brought to you by Prescott Pharmaceuticals. [read post]
31 Jan 2010, 4:32 am by IP Dragon
For those who missed it, in 2008, the Intellectual Property Association of Japan (IPAJ) published an interesting article by Parama Sinha Palit and Bhaskar Bhattacharya called 'Does Intellectual Property Laws in India and China Encourage Innovation'. [read post]
14 Oct 2011, 6:10 pm
Orange County - Noven Pharmaceuticals, Inc. has filed an action for patent infringement against Watson Pharmaceuticals, Inc. in a federal district court in New Jersey. [read post]
4 Sep 2017, 8:49 pm by Patent Docs
By Adrian M Trioli* & Noelene Treloar** -- The Australian Full Federal Court's recent decision in Commissioner of Patents v AbbVie Biotechnology Ltd [2017] FCAFC 129 confirms that an extension of patent term for pharmaceutical substances does not extend to Swiss type claims. [read post]
10 Nov 2020, 8:53 pm by Patent Docs
Brands LLC of prior Federal Circuit interpretations that venue was coincident with personal jurisdiction, last Thursday the Federal Circuit arrived at a decision regarding where proper venue does not lie in ANDA litigation, in Valeant Pharmaceuticals North America LLC v. [read post]
19 Jul 2018, 2:30 am by Eric Guttag
The post Jazz Pharmaceuticals: Does the Federal Circuit Really Understand the Dichotomy in the Printed Publication Bar? [read post]
13 Feb 2008, 11:21 pm
The pharmaceutical industry has made nurses "soft targets" for drug marketing purposes, but nursing education still does little to teach nurses to recognize and question pharmaceutical industry bias in marketing literature or sales tactics. [read post]
19 Mar 2013, 1:19 am by Sean Hayes
The most important issue for my foreign readers is that it is no longer true that Korea does not have vicarious liability. [read post]